Welcome to our dedicated page for ENVXW SEC filings (Ticker: ENVXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ENVXW SEC filings page focuses on regulatory documents related to the Enovix Corporation warrants that traded under the ENVXW symbol. These filings help explain how the warrant program was structured, how it evolved over time, and how the ENVXW class was ultimately removed from listing on the Nasdaq Stock Market.
Key filings include multiple Form 8-K reports in which Enovix describes material events affecting the warrants. These 8-Ks summarize press releases announcing the distribution of the warrants as a dividend, the satisfaction of early expiration price conditions tied to the volume-weighted average price of Enovix common stock, the election of an alternate expiration date, and the mechanics by which warrants had to be exercised before they became void. The filings also reference a Notice of Guaranteed Delivery that outlined procedures for warrant holders whose financial institutions could not complete exercises before the deadline.
A central document for ENVXW is the Form 25 filed with the SEC, in which Nasdaq notified the Commission of the removal of the Enovix warrant class from listing and registration under Section 12(b) of the Exchange Act. This filing confirms that the ENVXW warrants, described simply as “Warrant” in the form, were struck from the exchange following the conclusion of the program.
Through Stock Titan, users can access these filings as they appear on EDGAR, while AI-powered tools can assist in interpreting the implications. For ENVXW, that means quickly understanding the timeline from warrant issuance to expiration, the conditions that triggered early expiration, and the formal delisting process. Users interested in Enovix more broadly can also look to related filings under ENVX for annual reports on Form 10-K, quarterly reports on Form 10-Q, and additional 8-Ks that discuss financial results, capital markets transactions and governance changes.
In addition, investors researching historical capital structure or derivative securities can use the ENVXW filings to see how the warrant terms were documented in the warrant agreement, how the company communicated with holders, and how proceeds from exercises were reported in subsequent disclosures. AI summaries can highlight the sections that address warrant exercise prices, expiration conditions, and the impact on Enovix’s equity.
Ajay Marathe, Chief Operating Officer of Enovix Corporation, reported a routine equity withholding transaction on 08/14/2025. The filing shows 7,338 shares of common stock were disposed of at a price of $10.50 to satisfy tax withholding in connection with the vesting of restricted stock units (RSUs). After the withholding, the reporting person beneficially owns 1,157,015 shares, which includes 810,783 shares issuable upon settlement of RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Thurman J. Rodgers, a trustee of the Rodgers Massey Revocable Living Trust and a 10% owner and director of Enovix Corporation (ENVX), reported a bona fide gift of 500,000 publicly-traded warrants to a donor advised fund. The Warrants were originally distributed by the issuer on July 21, 2025 at no cost and each entitles the holder to purchase one share of common stock at an $8.75 exercise price. The reported transaction date is 08/14/2025. After the gift, the Reporting Person retains beneficial interest in Warrants underlying 2,414,466 shares held in the Trust. The Warrants expire on October 1, 2026, subject to early-acceleration terms in the Warrant Agreement.
Enovix Corporation appointed John Daniel (Dan) McCranie to its Board of Directors effective August 12, 2025, increasing the Board to eight members and identifying him as an independent director. Mr. McCranie previously served on Enovix’s Board and had been an audit committee member and chair of the compensation committee before his resignation effective January 20, 2023.
Under the company’s Non-Employee Director Compensation Policy, Mr. McCranie will receive a prorated annual cash retainer of $50,000, an initial restricted stock unit grant valued at $275,000 (vesting quarterly over three years), and a prorated annual RSU grant valued at $195,000 (vesting quarterly over one year or until the next annual meeting). He will sign the company’s standard director indemnification agreement. A press release is filed as Exhibit 99.1.
Arthi Chakravarthy, the Chief Legal Officer of Enovix Corporation, reported a transaction dated 08/08/2025 reflecting the withholding of 934 shares to satisfy tax-withholding obligations upon the vesting of restricted stock units (RSUs). The shares were withheld at an effective price of $10.78. After this withholding, the reporting person beneficially owns 428,183 shares directly, which includes 337,993 shares issuable upon settlement of RSUs that remain part of her beneficial stake. The filing shows no derivative transactions reported and is signed on 08/12/2025.
Raj Talluri, President and CEO and director of Enovix Corporation, reported a routine equity withholding related to RSU vesting on 08/08/2025. The filing shows 4,292 shares of the issuer's common stock were withheld to satisfy tax withholding obligations at a reported price of $10.78 per share in connection with the vesting of restricted stock units.
After the withholding, the reporting person is recorded as beneficially owning 2,400,818 shares (direct). That total explicitly includes 1,887,185 shares issuable upon settlement of outstanding RSUs granted to the reporting person.
Kristina Truong, Enovix's Chief Accounting Officer, reported a non-derivative equity transaction on 08/08/2025 in which 252 shares of common stock were withheld to satisfy tax withholding upon the vesting of restricted stock units (each RSU converts to one share). The withheld shares carry a reported per-share price of $10.78. The filing shows 206,860 shares beneficially owned following the transaction, which explicitly includes 173,141 shares issuable upon settlement of RSUs. This disclosure reflects a routine equity-compensation settlement and tax withholding rather than an open-market sale.
Ajay Marathe, listed as Chief Operating Officer, reported an RSU vesting-related transaction dated 08/08/2025. The issuer withheld 1,490 shares to satisfy tax withholding on vested restricted stock units. After the reported transaction Marathe is shown as beneficially owning 1,164,353 shares, which includes 824,667 shares issuable upon RSU settlement. The Form 4 was signed by an attorney-in-fact on 08/12/2025. No derivative transactions were reported.
Thurman J. Rodgers, a director and reported >10% owner of Enovix Corporation (ENVX), reported exercising 220,114 publicly-traded warrants into common stock at an $8.75 exercise price, with the resulting shares held by a charitable trust for which he is trustee. The filing shows 1,120,114 shares beneficially owned following the transaction in that trust and an additional 20,858,407 shares held indirectly by a separate revocable trust. The revocable trust also holds 2,914,466 warrants. The report notes 22,543 restricted stock units outstanding for the reporting person. The warrants were distributed by the issuer at no cost and expire on October 1, 2026.
Thurman J. Rodgers, a director and 10% owner of Enovix Corporation, reported on Form 4 that publicly distributed warrants were exercised on 08/08/2025, resulting in the acquisition of 57,142 shares at an exercise price of $8.75 per share. The filing states the warrants were distributed by the issuer on July 21, 2025 and will expire on October 1, 2026, subject to possible acceleration under the Warrant Agreement. Rodgers reports beneficial ownership through the Rodgers Massey Revocable Living Trust and the Rodgers Family Freedom and Free Markets Charitable Trust, for which he is trustee with voting and dispositive power, bringing reported beneficial ownership to 20,858,407 shares. The filing also discloses 22,543 restricted stock units that are contingent rights to common stock.
Raj Talluri K, President, CEO and a director of Enovix Corporation, reported on Form 4 that 22,857 shares of common stock were issued to him on 08/07/2025 upon the exercise of publicly-traded warrants. The warrants were distributed by the company on July 21, 2025 and carried an exercise price of $8.75 per share. After the transaction, the filing shows the reporting person beneficially owned 2,405,110 shares, which includes 1,895,306 shares issuable upon settlement of restricted stock units (RSUs). The Form 4 was signed by an attorney-in-fact on 08/11/2025.